An article published in the journal Gastroenterology & Hepatology highlights recent updates to eosinophilic gastrointestinal disease nomenclature, as well as updates related to diagnosis, pathogenesis ...

Please provide your email address to receive an email when new articles are posted on . A cohort of patients with atopic disease showed a high rate of gastrointestinal symptoms including food ...

Please provide your email address to receive an email when new articles are posted on . Patients with food allergies were 15.8 times more likely to develop eosinophilic esophagitis. The prevalence of ...

AstraZeneca’s Fasenra (benralizumab) has been approved by the US FDA for the treatment of adult and paediatric patients aged 12 years and older with hypereosinophilic syndrome (HES) without an ...

The good news: a monoclonal antibody treatment called benralizumab proved quite effective in a clinical trial at depleting the number of eosinophils found in the blood and digestive tract tissues of ...

Dr. Michael Wechsler, Professor of Medicine and Director of The Asthma Institute at National Jewish Health, and International Coordinating Investigator of the MANDARA trial said: “This approval is ...

An international team, including researchers from McMaster University and St. Joseph's Healthcare Hamilton, has identified a new therapeutic for patients with a rare autoimmune disease called ...

Share on Pinterest The condition eosinophilic esophagitis can make it difficult for children to eat. Westend61/Getty Images Researchers have published new research about eosinophilic esophagitis (EoE) ...

Hypereosinophilic syndrome is defined by persistent eosinophilia with eosinophil-mediated organ/tissue damage, driving ...

The monoclonal antibody countered some esophageal restructuring caused by inflammatory dri ...